|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Illumina Shows its Stuff to Wall Street, Stock Still Slides
|
Luke Timmerman |
11/07/08 |
San Diego
|
|
OVP, Enterprise Partners See Big Opportunity in $5,000 Human Genome Sequencing
|
Luke Timmerman |
10/07/08 |
San Diego
|
|
Helicos Names CTO to Boost R&D
|
Ryan McBride |
08/26/08 |
Boston
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
Boston
|
|
Helicos Forms Collaboration with Uppsala University Researchers
|
Luke Timmerman |
08/05/08 |
Boston
|
|
Helicos Looking to Grow in Bay State, Thanks to Gov. Patrick’s Life Sciences Initiative
|
Luke Timmerman |
07/31/08 |
Boston
|
|
Geospiza Cuts Deal With Illumina, To Help Scientists Cope With Information Overload
|
Luke Timmerman |
06/24/08 |
Seattle
|
|
What’s Ailing Personalized Medicine? Mark Levin Calls for Leadership at the Highest Level
|
Malorye Allison |
01/24/08 |
Boston
|
|
Page 2 of
2 |
« previous page |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.